MY148981A - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
MY148981A
MY148981A MYPI20020408A MY148981A MY 148981 A MY148981 A MY 148981A MY PI20020408 A MYPI20020408 A MY PI20020408A MY 148981 A MY148981 A MY 148981A
Authority
MY
Malaysia
Prior art keywords
units
sub
drug substance
dosage form
pharmaceutical formulation
Prior art date
Application number
Inventor
Stephen Mark Mcallister
Ronald K Raby Jr
Adrian Brown
Allan J Clarke
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Priority to MYPI20020408 priority Critical patent/MY148981A/en
Publication of MY148981A publication Critical patent/MY148981A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

THE PRESENT INVENTION IS DIRECTED TO PHARMACEUTICALLY ACCEPTABLE POLYMERIC COMPOSITIONS SUITABLE FOR INJECTION MOLDING OF SINGLE OR MULTI-COMPONENT PHARMACEUTICAL DOSAGE FORMS COMPRISING A PLURALITY OF DRUG SUBSTANCE CONTAINING SUB-UNITS, BEING CAPSULE COMPARTMENTS AND/OR SOLID SUB-UNITS COMPRISING A SOLID MATRIX OF A POLYMER WHICH, CONTAINS A DRUG SUBSTANCE, THE SUB-UNITS BEING CONNECTED TOGETHER IN THE ASSEMBLED DOSAGE FORM BY A WELD BETWEEN PARTS OF THE ASSEMBLED DOSAGE FORM.
MYPI20020408 2002-02-06 2002-02-06 Pharmaceutical formulation MY148981A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20020408 MY148981A (en) 2002-02-06 2002-02-06 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20020408 MY148981A (en) 2002-02-06 2002-02-06 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
MY148981A true MY148981A (en) 2013-06-28

Family

ID=50287819

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20020408 MY148981A (en) 2002-02-06 2002-02-06 Pharmaceutical formulation

Country Status (1)

Country Link
MY (1) MY148981A (en)

Similar Documents

Publication Publication Date Title
WO2002060384A3 (en) Pharmaceutical formulation
MXPA06000791A (en) Pharmaceutical formulations.
MX2010005092A (en) Pharmaceutical formulations.
MX2010013731A (en) Hydroxypropyl cellulose capsule shell.
NO20064570L (en) Pharmaceutical preparations
BR0012869A (en) Multi-component Pharmaceutical Dosage Form
EA200801926A1 (en) TABLETS OF PARACETAMOL WITH FAST DELIVERY
SI2529622T1 (en) Inhibitors of bruton's tyrosine kinase
HK1126394A1 (en) Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
MX2007015480A (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption.
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
EA200401252A1 (en) MICROPARTICLES OF MEDICINAL SUBSTANCES
WO2004112756A8 (en) Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
EA200700158A1 (en) MEDICAL FORMS WITH A TABLET NUCLEUS, COVERED WITH THE ENTEROROLEUBLISHING SHELL
BR0211198A (en) Pharmaceutical compositions and their use
DE602005008128D1 (en) Cytisine-containing drug
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
WO2007120838A3 (en) Rapidly disintegrating solid oral dosage form of liquid dispersions
MY148981A (en) Pharmaceutical formulation
TR200601092T1 (en) New oral pharmaceutical formulations containing the active ingredient irbesartan.
CA2532714A1 (en) Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
WO2005030132A3 (en) Therapeutic regimens for administering drug combinations
WO2008147245A3 (en) Controlled release proxodolol pharmaceutical composition
MY145885A (en) Controlled release formulations for oral administration